Positron Emission Tomography - Computed Tomography (PET-CT) Scan as a Diagnostic Method in Unknown Primary Tumors

Unknown Primary Tumor Clinical Trial

Official title:

PET-CT Scan as a Diagnostic Method in Unknown Primary Tumors

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00269373
• Other study ID #: 01 283694
• Status: Completed
• Phase: N/A
• First received: December 22, 2005
• Last updated: February 20, 2012
• Start date: December 2005
• Est. completion date: February 2012

Study information

• Verified date: February 2012
• Source: Rigshospitalet, Denmark
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: Ethics Committee
• Study type: Observational

Clinical Trial Summary

Is PET-CT scan better than PET or CT alone in diagnosing primary tumours in patients with unknown primary tumors? Can information obtained with PET-CT replace other clinical and radiological investigations? Is PET/CT cost-effective?

Description:

Patients who fulfill the international definition of unknown primary tumors can be included, except:

• Young men (<55 years) with growing mid-line tumors where a germ cell tumor could be expected will not be included.

• Patients with lymph-node metastases with squamous cell carcinoma in the head and neck region will not be included.

• Women with adenocarcinoma in lymph nodes in the axilla will not be included.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 136
• Est. completion date: February 2012
• Est. primary completion date: February 2012
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years to 75 Years

Eligibility

Inclusion Criteria:

• Unknown primary tumors

Exclusion Criteria:

• Young men (<55 years) with growing mid-line tumors where a germ cell tumor could be expected will not be included.

• Patients with lymph-node metastases with squamous cell carcinoma in the head and neck region will not be included

• Women with adenocarcinoma in lymph nodes in the axilla will not be included

Study Design

Observational Model: Cohort, Time Perspective: Prospective

Related Conditions & MeSH terms

• Neoplasms, Unknown Primary
• Unknown Primary Tumor

Intervention

Procedure:
• PET-CT
no drugs included

Locations

Country	Name	City	State
Denmark	Rigshospitalet	Copenhagen

Sponsors (1)

Lead Sponsor	Collaborator
Rigshospitalet, Denmark

Country where clinical trial is conducted

Denmark,